112 related articles for article (PubMed ID: 31934178)
21. LIMD2 targeted by miR‑34a promotes the proliferation and invasion of non‑small cell lung cancer cells.
Wang F; Li Z; Xu L; Li Y; Li Y; Zhang X; Wang Y; Liu D
Mol Med Rep; 2018 Nov; 18(5):4760-4766. PubMed ID: 30221696
[TBL] [Abstract][Full Text] [Related]
22. Clinical Significance and Systematic Expression Analysis of the Thyroid Receptor Interacting Protein 13 (TRIP13) as Human Gliomas Biomarker.
Chen SH; Lin HH; Li YF; Tsai WC; Hueng DY
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34066132
[TBL] [Abstract][Full Text] [Related]
23. Targeting H19 by lentivirus-mediated RNA interference increases A549 cell migration and invasion.
Wang L; Sun Y; Yi J; Wang X; Liang J; Pan Z; Li L; Jiang G
Exp Lung Res; 2016 Sep; 42(7):346-353. PubMed ID: 27607135
[TBL] [Abstract][Full Text] [Related]
24. Mechanistic insight into TRIP13-catalyzed Mad2 structural transition and spindle checkpoint silencing.
Brulotte ML; Jeong BC; Li F; Li B; Yu EB; Wu Q; Brautigam CA; Yu H; Luo X
Nat Commun; 2017 Dec; 8(1):1956. PubMed ID: 29208896
[TBL] [Abstract][Full Text] [Related]
25. Effects of Linc00460 on cell migration and invasion through regulating epithelial-mesenchymal transition (EMT) in non-small cell lung cancer.
Yue QY; Zhang Y
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1003-1010. PubMed ID: 29509248
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
Jing H; Xia H; Qian M; Lv X
Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
[TBL] [Abstract][Full Text] [Related]
27. FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.
Yang T; Li H; Thakur A; Chen T; Xue J; Li D; Chen M
Tumour Biol; 2015 Sep; 36(10):8185-91. PubMed ID: 25994569
[TBL] [Abstract][Full Text] [Related]
28. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
29. LncRNA BCAR4 promotes proliferation, invasion and metastasis of non-small cell lung cancer cells by affecting epithelial-mesenchymal transition.
Li N; Gao WJ; Liu NS
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2075-2086. PubMed ID: 28537678
[TBL] [Abstract][Full Text] [Related]
30. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis.
Ye L; Pu C; Tang J; Wang Y; Wang C; Qiu Z; Xiang T; Zhang Y; Peng W
Respir Res; 2019 May; 20(1):106. PubMed ID: 31142317
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of Immature Colon Carcinoma Transcript 1 Inhibits Proliferation and Promotes Apoptosis of Non-Small Cell Lung Cancer Cells.
Wang Y; He J; Zhang S; Yang Q; Wang B; Liu Z; Wu X
Technol Cancer Res Treat; 2017 Oct; 16(5):559-569. PubMed ID: 27413166
[TBL] [Abstract][Full Text] [Related]
32. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
Xia LH; Yan QH; Sun QD; Gao YP
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827
[TBL] [Abstract][Full Text] [Related]
33. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
He R; Zhang FH; Shen N
Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
[TBL] [Abstract][Full Text] [Related]
34. Role of CCT chaperonin in the disassembly of mitotic checkpoint complexes.
Kaisari S; Sitry-Shevah D; Miniowitz-Shemtov S; Teichner A; Hershko A
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):956-961. PubMed ID: 28096334
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
[TBL] [Abstract][Full Text] [Related]
36. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
37. TRIP13 and APC15 drive mitotic exit by turnover of interphase- and unattached kinetochore-produced MCC.
Kim DH; Han JS; Ly P; Ye Q; McMahon MA; Myung K; Corbett KD; Cleveland DW
Nat Commun; 2018 Oct; 9(1):4354. PubMed ID: 30341343
[TBL] [Abstract][Full Text] [Related]
38. Baicalein suppresses non small cell lung cancer cell proliferation, invasion and Notch signaling pathway.
Su G; Chen H; Sun X
Cancer Biomark; 2018; 22(1):13-18. PubMed ID: 29614624
[TBL] [Abstract][Full Text] [Related]
39. [Regulation of TRIP13 on Proliferation and Apoptosis of B-Cell Lymphoma Cells and Its Mechanism].
Yan SR; Zhang Q; Liu XC; Yuan JJ; Zhang F; Zhou KS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1485-1492. PubMed ID: 34627428
[TBL] [Abstract][Full Text] [Related]
40. The oncogenic role of CB2 in the progression of non-small-cell lung cancer.
Xu S; Ma H; Bo Y; Shao M
Biomed Pharmacother; 2019 Sep; 117():109080. PubMed ID: 31176172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
